For locally advanced rectal cancer, will the recent update of RAPIDO lead you to change your practice when approaching TNT?
Specifically, will the higher rate of local failure in the TNT (short-course RT) arm lead you to consider a TNT approach with long-course CRT?
Dijkstra et al., PMID 36661037
2 Answers
Mednet MemberInvited Expert
Radiation Oncology · Memorial Sloan-Kettering Cancer Center
Answered on
We prefer long course chemoradiation followed by consolidation with FOLFOX and non-operative management based on the OPRA trial, which reported 60% versus 40% using this sequence versus initial chemotherapy.
Join for free or sign in to see the full answer
Mednet MemberInvited Expert
Radiation Oncology · Mayo Clinic School of Medicine
Answered on · Updated on
There are a number of subtleties regarding risk factors and their association with competing risks of distant vs locoregional relapse that influence my decision-making regarding short vs long course and in some capacity, sequence of therapies. I do use short course quite frequently (~60% I’d estimat...
Join for free or sign in to see the full answer